⌘K
Loading ticker…
As of 2026-08-24, Phathom Pharmaceuticals, Inc. Common Stock (PHAT) has a 3-month relative strength percentile of 18 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 40. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.6%, relative volume 0.56×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
PHAT is in a stage 4 downtrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -16.1% / -29.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
PHAT is held by 20 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $2M notional. Top 3 carry $6M.
Held by 36 ETFs · $70M across latest filings · largest weight 4.20% (SURI).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $2M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $2M | — |
| VHTVanguard Health Care ETF | 0.01% | $1M | — |
| VFMO | 0.04% | $751K | −0.05 pp |
| GSSC | 0.05% | $475K | new |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $321K |
| — |
| VTWV | 0.02% | $260K | — |
| VTWG | 0.01% | $111K | — |
| IBBQ | 0.06% | $41K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $33K | — |
Showing 10 of 20 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PHAT Jan avg: -16.03% median: -21.92% win: 25% σ: 15.47% n: 4 2022-04-12 → 2026-07-31 | PHAT Feb avg: 3.87% median: -7.98% win: 25% σ: 38.43% n: 4 2022-04-12 → 2026-07-31 | PHAT Mar avg: -3.82% median: -6.15% win: 25% σ: 13.36% n: 4 2022-04-12 → 2026-07-31 | PHAT Apr avg: -1.97% median: -13.96% win: 40% σ: 31.16% n: 5 2022-04-12 → 2026-07-31 | PHAT May avg: -9.13% median: -0.93% win: 40% σ: 21.77% n: 5 2022-04-12 → 2026-07-31 | PHAT Jun avg: 37.52% median: 17.71% win: 100% σ: 49.49% n: 5 2022-04-12 → 2026-07-31 | PHAT Jul avg: -0.04% median: 6.21% win: 60% σ: 14.44% n: 5 2022-04-12 → 2026-07-31 | PHAT Aug avg: 17.43% median: 17.19% win: 50% σ: 27.47% n: 4 2022-04-12 → 2026-07-31 (current) | PHAT Sep avg: 1.97% median: 3.04% win: 50% σ: 24.15% n: 4 2022-04-12 → 2026-07-31 | PHAT Oct avg: -1.17% median: -4.74% win: 25% σ: 11.18% n: 4 2022-04-12 → 2026-07-31 | PHAT Nov avg: -15.92% median: -15.34% win: 25% σ: 27.09% n: 4 2022-04-12 → 2026-07-31 | PHAT Dec avg: 10.20% median: 9.32% win: 75% σ: 16.18% n: 4 2022-04-12 → 2026-07-31 |